Decentralized clinical trials: regulatory perspectives in Russia and the EAEU
https://doi.org/10.37489/2782-3784-myrwd-32
EDN: WHBLHF
Abstract
This article describes regulatory approaches to the decentralized clinical trials (in whole or in part) in international practice, as well as in the Russian Federation and the Eurasian Economic Union.
About the Authors
M. A. Borzova
«Trubor» Law Firm
Russian Federation
Competing Interests:
Russian Federation
Borzova Maria A. — counsel
RSCI AuthorID: 1203157
Moscow
Competing Interests:
The authors declare no conflict of interest.
S. V. Semina
«Trubor» Law Firm
Russian Federation
Competing Interests:
Russian Federation
Semina Sofia V. — paralegal
Moscow
Competing Interests:
The authors declare no conflict of interest.
References
1. European Commission’s Pharmaceutical Strategy for Europe. Доступно по адресу: https://health.ec.europa.eu/system/files/2021-02/pharma-strategy_report_en_0.pdf.
2. Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic Доступно по адресу: https://health.ec.europa.eu/system/files/2022-02/guidanceclinicaltrials_covid19_en_1.pdf.
3. European Medicines Agencies Network Strategy to 2025. Доступно по адресу: https://www.ema.europa.eu/en/documents/report/european-union-medicines-agencies-network-strategy-2025-protecting-public-health-time-rapid-change_en.pdf.
4. Design Concept for a Confirmatory Basket Trial. Доступно по адресу: https://www.ema.europa.eu/en/documents/presentation/presentation-session-5-design-concept-confirmatory-basket-trial-robert-beckman_en.pdf.
5. Accelerating Clinical Trials in the EU (ACT EU). Доступно по адресу: https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/accelerating-clinical-trials-eu-act-eu
6. Accelerating Clinical Trials Workplan. Доступно по адресу: https://www.ema.europa.eu/en/documents/other/act-eu-multi-annual-workplan-2022-2026_en.pdf.
7. Recommendation paper on decentralized elements in clinical trials. Доступно по адресу: https://health.ec.europa.eu/latest-updates/recommendation-paper-decentralised-elements-clinical-trials-2022-12-14_en.
8. Facilitating Decentralised Clinical Trials in the EU. Доступно по адресу: См. https://www.ema.europa.eu/en/news/facilitating-decentralised-clinical-trials-eu.
9. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective. Доступно по адресу: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2628.
10. Guidance for Industry, Investigators, and Institutional Review Boards: Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency. Доступно по адресу: https://www.fda.gov/media/136238/download.
11. Draft Guidance. Digital Health Technologies for Remote Data Acquisition in Clinical Investigations: Guidance for Industry, Investigators, and Other Stakeholders. Доступно по адресу: https://www.fda.gov/media/155022/download.
12. Clinical Trials Transformation Initiative. Официальный сайт в сети «Интернет»: https://ctti-clinicaltrials.org/who_we_are/.
13. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative. Доступно по адресу: https://link.springer.com/article/10.1007/s43441-019-00006-4.
Review
For citations:
Borzova M.A., Semina S.V. Decentralized clinical trials: regulatory perspectives in Russia and the EAEU. Real-World Data & Evidence. 2023;3(2):10-20. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-32. EDN: WHBLHF
Views:
949
Email this article 
Post a Comment 